Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John L Petersen

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Current Cardiology Reports|July 10, 2008
Early intervention: which patients and how early?J Matthew Brennan, John L Petersen
Current Treatment Options in Cardiovascular Medicine|January 13, 2006
Obesity, diabetes, and associated risk factorsWael A AlJaroudi, John L Petersen
Diabetes & Vascular Disease Research|November 25, 2005
Impaired glucose tolerance and impaired fasting glucose--a review of diagnosis, clinical implications and managementJohn L Petersen, Darren K McGuire
American Heart Journal|April 23, 2005
Revascularization of coronary atherosclerosis in patients with diabetes mellitus--there is more to it than meets the image intensifierJohn L Petersen, Robert A Harrington
The Annals of Thoracic Surgery|December 4, 2019
Invited CommentaryEric J Lehr, John L Petersen
Current Cardiology Reports|June 9, 2004
The evaluation and management of dyslipidemia and impaired glucose metabolism during acute coronary syndromesAbhinav Goyal, John L Petersen, Kenneth W Mahaffey
Current Diabetes Reports|September 17, 2003
Advances and continued controversy in coronary revascularization of patients with diabetes mellitusJohn L Petersen, Darren K McGuire, Robert A Harrington
Circulation. Cardiovascular Interventions|December 25, 2009
Vascular disease burden and in-hospital outcomes among patients undergoing percutaneous coronary intervention in New York StateJeffrey S Berger, John L Petersen, David L Brown
Journal of the American Mosquito Control Association|July 22, 2004
Diagnostic dose of synergized d-phenothrin for insecticide susceptibility testing by bottle bioassayJohn L Petersen, Thomas G Floore, William G Brogdon
Future Cardiology|October 7, 2009
Clinical implications of vulnerable plaqueJeffrey S Berger, John L Petersen, James E Tcheng, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Current Cardiology Reports|July 10, 2008
Early intervention: which patients and how early?J Matthew Brennan, John L Petersen
Current Treatment Options in Cardiovascular Medicine|January 13, 2006
Obesity, diabetes, and associated risk factorsWael A AlJaroudi, John L Petersen
Diabetes & Vascular Disease Research|November 25, 2005
Impaired glucose tolerance and impaired fasting glucose--a review of diagnosis, clinical implications and managementJohn L Petersen, Darren K McGuire
American Heart Journal|April 23, 2005
Revascularization of coronary atherosclerosis in patients with diabetes mellitus--there is more to it than meets the image intensifierJohn L Petersen, Robert A Harrington
The Annals of Thoracic Surgery|December 4, 2019
Invited CommentaryEric J Lehr, John L Petersen
Current Cardiology Reports|June 9, 2004
The evaluation and management of dyslipidemia and impaired glucose metabolism during acute coronary syndromesAbhinav Goyal, John L Petersen, Kenneth W Mahaffey
Current Diabetes Reports|September 17, 2003
Advances and continued controversy in coronary revascularization of patients with diabetes mellitusJohn L Petersen, Darren K McGuire, Robert A Harrington
Circulation. Cardiovascular Interventions|December 25, 2009
Vascular disease burden and in-hospital outcomes among patients undergoing percutaneous coronary intervention in New York StateJeffrey S Berger, John L Petersen, David L Brown
Journal of the American Mosquito Control Association|July 22, 2004
Diagnostic dose of synergized d-phenothrin for insecticide susceptibility testing by bottle bioassayJohn L Petersen, Thomas G Floore, William G Brogdon
Future Cardiology|October 7, 2009
Clinical implications of vulnerable plaqueJeffrey S Berger, John L Petersen, James E Tcheng, et al.
Pageof 4